StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3028% below fair value
$46.56+0.18 (+0.39%)

Close on Nov 20, 2026Market cap $1.39BP/E 19.2Yield 1.29%

Conmed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Conmed's free cash flow for the twelve months ending Sep 30, 2026 was $132.69M, down 10.9% year over year. For fiscal 2025 it was $150.88M, down 2.0% from the year before. Over ten years it grew 15.4% a year on average. The highest annual figure on record is $153.88M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$150.88M-2.0%
FY2024Dec 31, 2024$153.88M+44.7%
FY2023Dec 31, 2023$106.32M+818.1%
FY2022Dec 31, 2022$11.58M-88.1%
FY2021Dec 31, 2021$96.90M+88.1%
FY2020Dec 31, 2020$51.52M-31.4%
FY2019Dec 31, 2019$75.07M+29.0%
FY2018Dec 31, 2018$58.19M+10.4%
FY2017Dec 31, 2017$52.72M+109.8%
FY2016Dec 31, 2016$25.13M-30.0%
FY2015Dec 31, 2015$35.91M-27.8%
FY2014Dec 31, 2014$49.77M-20.4%
FY2013Dec 31, 2013$62.50M-15.2%
FY2012Dec 31, 2012$73.67M-13.8%
FY2011Dec 31, 2011$85.44M+263.4%
FY2010Dec 31, 2010$23.51M+556.0%
FY2009Dec 31, 2009$3.58M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$46.73M-3.7%
Q2 FY2026Jun 30, 2026$34.16M+46.0%
Q1 FY2026Mar 31, 2026$10.58M-72.0%
Q4 FY2025Dec 31, 2025$41.22M+4.9%
Q3 FY2025Sep 30, 2025$48.50M+1.5%
Q2 FY2025Jun 30, 2025$23.41M-41.1%
Q1 FY2025Mar 31, 2025$37.76M+39.4%
Q4 FY2024Dec 31, 2024$39.30M-23.8%
Q3 FY2024Sep 30, 2024$47.78M+17.3%
Q2 FY2024Jun 30, 2024$39.72M+79.4%
Q1 FY2024Mar 31, 2024$27.09M–
Q4 FY2023Dec 31, 2023$51.54M–
Q3 FY2023Sep 30, 2023$40.73M+112.4%
Q2 FY2023Jun 30, 2023$22.14M+69.9%
Q1 FY2023Mar 31, 2023-$8.10M–
Q4 FY2022Dec 31, 2022-$17.27M-156.5%
Q3 FY2022Sep 30, 2022$19.18M+21.5%
Q2 FY2022Jun 30, 2022$13.03M-58.3%
Q1 FY2022Mar 31, 2022-$3.36M-117.5%
Q4 FY2021Dec 31, 2021$30.60M+80.0%
Q3 FY2021Sep 30, 2021$15.79M-50.4%
Q2 FY2021Jun 30, 2021$31.29M+1650.7%
Q1 FY2021Mar 31, 2021$19.24M+2046.8%
Q4 FY2020Dec 31, 2020$17.00M-51.0%
Q3 FY2020Sep 30, 2020$31.84M+0.3%
Q2 FY2020Jun 30, 2020$1.79M-89.2%
Q1 FY2020Mar 31, 2020$896.00K–
Q4 FY2019Dec 31, 2019$34.69M+73.9%
Q3 FY2019Sep 30, 2019$31.73M–
Q2 FY2019Jun 30, 2019$16.59M-3.1%
Q1 FY2019Mar 31, 2019-$7.94M-137.4%
Q4 FY2018Dec 31, 2018$19.95M+16.0%
Q3 FY2018Sep 30, 2018-$109.00K-101.1%
Q2 FY2018Jun 30, 2018$17.12M+30.8%
Q1 FY2018Mar 31, 2018$21.24M+67.1%
Q4 FY2017Dec 31, 2017$17.20M+83.5%
Q3 FY2017Sep 30, 2017$9.72M–
Q2 FY2017Jun 30, 2017$13.09M–
Q1 FY2017Mar 31, 2017$12.71M–
Q4 FY2016Dec 31, 2016$9.38M–

More Conmed figures

See a number that looks wrong?